Bharat Biotech's Intranasal Covid-19 Vaccine Completes Phase 2 Trials: Krishna Ella
What Can Possibly Explain WHO's Delay In Approving Covaxin?
ZyCoV-D: India's Homegrown Three-Dose Covid-19 Vaccine For Anyone Over 12, Approved For Emergency Use
Bharat Biotech's Krishna Ella Says Company Working On A Combo Of Covaxin And Nasal Vaccine For Booster Dose
What We Know About Union Health Minister's Meeting With WHO Chief Scientist
Ahmedabad Based Zydus Cadila Seeks DCGI Nod For Phase-3 Clinical Trials Of Its COVID-19 Vaccine With 30,000 Volunteers
